Pseudoscience in medicine: cautionary recommendations.


Journal

African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451

Informations de publication

Date de publication:
Dec 2019
Historique:
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 30 9 2020
Statut: ppublish

Résumé

Certain real life applications of scientific and social science ideas that knowingly reject accumulated empirical biomedical evidence have been termed 'pseudoscience,' or empirical rejectionism. An uncritical acceptance of empiricism, or even of evidence-based medicine, however, can also be problematic. With reference to a specific type of medical denialism associated with moral failure, justified by dissident AIDS and anti-vaccine scientific publications, this paper seeks to make the argument that this type of denialism meets certain longstanding definitions for classification as pseudoscience. This paper uses a conceptual framework to make certain arguments and to juxtapose arguments for evidence-based approaches to medicine against literature that highlights certain limitations of an unquestioning approach to empiricism. Discussions of certain real life examples are used to derive the important insight that, under certain conditions, moral failure can result in the violation both Type I and Type II scientific error types, with catastrophic consequences. It is argued that the validity of all theory should not be assumed before sufficient empirical evidence has accumulated to support its validity across contexts. However, caution is required, to avoid the consequences of an unquestioning approach to empiricism.

Identifiants

pubmed: 32127888
doi: 10.4314/ahs.v19i4.34
pii: jAFHS.v19.i4.pg3118
pmc: PMC7040346
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3118-3126

Informations de copyright

© 2019 Callaghan C.

Références

J Virol. 2013 Jul;87(14):7790-2
pubmed: 23678167
Lancet. 1998 Feb 28;351(9103):637-41
pubmed: 9500320
J Evid Based Soc Work. 2014;11(3):269-74
pubmed: 24857555
Am J Public Health. 1998 Jul;88(7):1105-17
pubmed: 9663166
BMJ. 2011 Jan 05;342:c5347
pubmed: 21209059
Lancet. 1999 Sep 11;354(9182):949-50
pubmed: 10489978
Mayo Clin Proc. 2011 Sep;86(9):869-71
pubmed: 21878599
N Engl J Med. 2009 Nov 12;361(20):1925-34
pubmed: 19815860
BMJ. 2011 Jan 18;342:c7001
pubmed: 21245118
Am J Bioeth. 2015;15(7):77-9
pubmed: 26147281
Chest. 1994 May;105(5):1309-10
pubmed: 8181310
Am J Public Health. 2002 May;92(5):725-9
pubmed: 11988435
JAMA. 2005 Jul 13;294(2):218-28
pubmed: 16014596
Am J Public Health. 1998 Jul;88(7):1014-5
pubmed: 9663143
Qual Saf Health Care. 2004 Jun;13(3):233-4
pubmed: 15175497
Science. 1988 Jul 29;241(4865):514, 517
pubmed: 3399880

Auteurs

Chris Callaghan (C)

University of the Witwatersrand, School of Economic and Business Sciences.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH